Ultrasound Evaluation for Cardiac Surgery

(UTF-in-CVICU Trial)

Not yet recruiting at 1 trial location
WB
Overseen ByWilliam Beaubien-Souligny, MD, PhD, FRCPC
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This pilot randomized controlled trial will evaluate the use of point-of-care ultrasound (POCUS) to assess fluid tolerance and fluid responsiveness in patients following cardiac surgery. Participants will be randomized to an ultrasound-guided assessment strategy or standard care. In the intervention group, treating physicians will receive the results of a structured ultrasound assessment, including the Venous Excess UltraSound (VExUS) score and an assessment of fluid responsiveness.

The primary objectives are to determine whether this information influences clinical management and to assess the feasibility of the study procedures. The study will also explore differences in fluid and hemodynamic management, kidney function, and postoperative clinical outcomes.

Are You a Good Fit for This Trial?

This trial is for adults who have recently had heart surgery. It aims to include patients in the recovery period after their operation, but specific inclusion and exclusion criteria are not detailed here.

Inclusion Criteria

I am 18 years old or older.
I am scheduled for heart surgery and will stay in the ICU afterward.

Exclusion Criteria

I am using or planning to use a heart-assist device.
I have stage 5 chronic kidney disease or need dialysis.
I have had or am planning to have a heart transplant.

What Are the Treatments Tested in This Trial?

Trial Overview

The study compares two ways of managing fluids after heart surgery: one group gets ultrasound-guided fluid assessments, while the other receives standard care without extra ultrasound guidance. Patients are randomly assigned to each group.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: POCUS-Guided assessmentExperimental Treatment1 Intervention
Group II: Standard CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Centre hospitalier de l'Université de Montréal (CHUM)

Lead Sponsor

Trials
389
Recruited
143,000+

Montreal Heart Institute

Collaborator

Trials
125
Recruited
85,400+